ACN Newswire

Sat Nov 14

Fujitsu: Establishment of Joint Venture Aimed at the Development of Therapeutics for the Treatment of Coronavirus Disease

Written by ACN Newswire

TOKYO, Nov 13, 2020 - (JCN Newswire) - PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (TSE:4587), Fujitsu Limited (TSE:6702), Mizuho Capital Co., Ltd. which is a consolidated subsidiary of Mizuho Financial Group, Inc., Takenaka Corporation and KISHIDA CHEMICAL CO., LTD. have agreed today to establish PeptiAID Inc., a joint...

Read more: Fujitsu: Establishment of Joint Venture Aimed at the Development of Therapeutics for the Treatment...

ACN Newswire

Fujitsu: Establishment of Joint Venture Aimed at the Development of Therapeutics for the Treatment of Coronavirus Disease

Citizen science: how you can contribute to coronavirus research without leaving the house

Balancing work and tertiary study is harder now than in 2012: study

Viewpoints: should teaching students who fail a literacy and numeracy test be barred from teaching?

Australian universities can't rely on India if funds from Chinese students start to fall

What You Need To Know About The Number One Durian Cake Maker In Singapore

Research Check: will eating 'ultra-processed' foods give you cancer?

Most people don't benefit from vaccination, but we still need it to prevent infections

How highly sexualised imagery is shaping 'influence' on Instagram - and harassment is rife

Older people are more digitally savvy, but aged care providers need to keep up

Turnbull pushes the 'reset' button with China, but will it be enough?

VIDEO: Michelle Grattan on the Extinction Rebellion protests - and Australia's responsibility at the Turkish-Syrian border